vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Loews Corporation (L). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $827.0M, roughly 1.2× Loews Corporation). Loews Corporation runs the higher net margin — 48.6% vs 7.7%, a 40.9% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 4.8%). Loews Corporation produced more free cash flow last quarter ($426.0M vs $96.9M). Over the past eight quarters, Loews Corporation's revenue compounded faster (7.9% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Loews Corporation is a diversified US-based conglomerate that operates across multiple key industry segments through its subsidiaries. Its core business lines include property and casualty insurance, natural gas pipeline transportation, hospitality services, and upstream oil and gas exploration and production, primarily serving commercial, consumer and industrial clients across North American markets.

ATR vs L — Head-to-Head

Bigger by revenue
ATR
ATR
1.2× larger
ATR
$962.7M
$827.0M
L
Growing faster (revenue YoY)
ATR
ATR
+8.7% gap
ATR
13.5%
4.8%
L
Higher net margin
L
L
40.9% more per $
L
48.6%
7.7%
ATR
More free cash flow
L
L
$329.1M more FCF
L
$426.0M
$96.9M
ATR
Faster 2-yr revenue CAGR
L
L
Annualised
L
7.9%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
L
L
Revenue
$962.7M
$827.0M
Net Profit
$74.3M
$402.0M
Gross Margin
Operating Margin
11.0%
65.4%
Net Margin
7.7%
48.6%
Revenue YoY
13.5%
4.8%
Net Profit YoY
-26.4%
115.0%
EPS (diluted)
$1.13
$1.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
L
L
Q4 25
$962.7M
$827.0M
Q3 25
$961.1M
$732.0M
Q2 25
$966.0M
$769.0M
Q1 25
$887.3M
$846.0M
Q4 24
$848.1M
$789.0M
Q3 24
$909.3M
$683.0M
Q2 24
$910.1M
$711.0M
Q1 24
$915.4M
$710.0M
Net Profit
ATR
ATR
L
L
Q4 25
$74.3M
$402.0M
Q3 25
$127.9M
$504.0M
Q2 25
$111.7M
$391.0M
Q1 25
$78.8M
$370.0M
Q4 24
$100.9M
$187.0M
Q3 24
$100.0M
$401.0M
Q2 24
$90.5M
$369.0M
Q1 24
$83.1M
$457.0M
Operating Margin
ATR
ATR
L
L
Q4 25
11.0%
65.4%
Q3 25
14.2%
94.1%
Q2 25
14.9%
70.1%
Q1 25
12.8%
60.8%
Q4 24
14.2%
23.8%
Q3 24
15.2%
80.5%
Q2 24
13.8%
71.3%
Q1 24
12.2%
88.6%
Net Margin
ATR
ATR
L
L
Q4 25
7.7%
48.6%
Q3 25
13.3%
68.9%
Q2 25
11.6%
50.8%
Q1 25
8.9%
43.7%
Q4 24
11.9%
23.7%
Q3 24
11.0%
58.7%
Q2 24
9.9%
51.9%
Q1 24
9.1%
64.4%
EPS (diluted)
ATR
ATR
L
L
Q4 25
$1.13
$1.93
Q3 25
$1.92
$2.43
Q2 25
$1.67
$1.87
Q1 25
$1.17
$1.74
Q4 24
$1.48
$0.87
Q3 24
$1.48
$1.82
Q2 24
$1.34
$1.67
Q1 24
$1.23
$2.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
L
L
Cash + ST InvestmentsLiquidity on hand
$409.5M
$6.0B
Total DebtLower is stronger
$1.1B
$8.4B
Stockholders' EquityBook value
$2.7B
$18.7B
Total Assets
$5.3B
$86.3B
Debt / EquityLower = less leverage
0.43×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
L
L
Q4 25
$409.5M
$6.0B
Q3 25
$264.8M
$5.4B
Q2 25
$169.8M
$4.5B
Q1 25
$136.8M
$4.4B
Q4 24
$226.2M
$4.6B
Q3 24
$327.9M
$5.2B
Q2 24
$223.9M
$4.9B
Q1 24
$201.1M
$5.4B
Total Debt
ATR
ATR
L
L
Q4 25
$1.1B
$8.4B
Q3 25
$546.0M
$8.4B
Q2 25
$535.1M
$7.9B
Q1 25
$561.2M
$8.4B
Q4 24
$688.1M
$8.9B
Q3 24
$822.7M
$8.8B
Q2 24
$681.5M
$8.6B
Q1 24
$680.4M
$8.4B
Stockholders' Equity
ATR
ATR
L
L
Q4 25
$2.7B
$18.7B
Q3 25
$2.8B
$18.3B
Q2 25
$2.7B
$17.5B
Q1 25
$2.5B
$17.2B
Q4 24
$2.5B
$17.1B
Q3 24
$2.5B
$17.4B
Q2 24
$2.4B
$16.4B
Q1 24
$2.3B
$16.2B
Total Assets
ATR
ATR
L
L
Q4 25
$5.3B
$86.3B
Q3 25
$5.1B
$85.9B
Q2 25
$4.9B
$84.7B
Q1 25
$4.5B
$83.1B
Q4 24
$4.4B
$81.9B
Q3 24
$4.6B
$83.6B
Q2 24
$4.5B
$81.1B
Q1 24
$4.4B
$80.9B
Debt / Equity
ATR
ATR
L
L
Q4 25
0.43×
0.45×
Q3 25
0.20×
0.46×
Q2 25
0.20×
0.45×
Q1 25
0.22×
0.49×
Q4 24
0.28×
0.52×
Q3 24
0.32×
0.51×
Q2 24
0.28×
0.52×
Q1 24
0.29×
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
L
L
Operating Cash FlowLast quarter
$183.7M
$617.0M
Free Cash FlowOCF − Capex
$96.9M
$426.0M
FCF MarginFCF / Revenue
10.1%
51.5%
Capex IntensityCapex / Revenue
9.0%
23.1%
Cash ConversionOCF / Net Profit
2.47×
1.53×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$2.7B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
L
L
Q4 25
$183.7M
$617.0M
Q3 25
$177.6M
$920.0M
Q2 25
$126.0M
$1.0B
Q1 25
$82.7M
$736.0M
Q4 24
$178.2M
$941.0M
Q3 24
$229.3M
$934.0M
Q2 24
$143.6M
$952.0M
Q1 24
$92.3M
$198.0M
Free Cash Flow
ATR
ATR
L
L
Q4 25
$96.9M
$426.0M
Q3 25
$114.3M
$764.0M
Q2 25
$62.5M
$872.0M
Q1 25
$25.9M
$638.0M
Q4 24
$112.2M
$767.0M
Q3 24
$162.7M
$794.0M
Q2 24
$75.4M
$793.0M
Q1 24
$16.7M
$39.0M
FCF Margin
ATR
ATR
L
L
Q4 25
10.1%
51.5%
Q3 25
11.9%
104.4%
Q2 25
6.5%
113.4%
Q1 25
2.9%
75.4%
Q4 24
13.2%
97.2%
Q3 24
17.9%
116.3%
Q2 24
8.3%
111.5%
Q1 24
1.8%
5.5%
Capex Intensity
ATR
ATR
L
L
Q4 25
9.0%
23.1%
Q3 25
6.6%
21.3%
Q2 25
6.6%
17.4%
Q1 25
6.4%
11.6%
Q4 24
7.8%
22.1%
Q3 24
7.3%
20.5%
Q2 24
7.5%
22.4%
Q1 24
8.3%
22.4%
Cash Conversion
ATR
ATR
L
L
Q4 25
2.47×
1.53×
Q3 25
1.39×
1.83×
Q2 25
1.13×
2.57×
Q1 25
1.05×
1.99×
Q4 24
1.77×
5.03×
Q3 24
2.29×
2.33×
Q2 24
1.59×
2.58×
Q1 24
1.11×
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

L
L

Transportation And Storage Of Natural Gas And NG Ls And Ethane Supply And Transportation Services$601.0M73%
Lodging And Related Services$226.0M27%

Related Comparisons